Uncertainty About the Benefits of New Cancer Drugs and Patients' Treatment Preferences
18h agoen
From the article
Conditions : Cancer Interventions : Other: Control; Other: Unvalidates surrogate endpoint; Other: Limited study population; Other: Small magnitude of effect; Other: Multiple uncertainties Sponsors : London School of Economics and Political Science; Harvard Medical School and Harvard Pilgrim Health Care Institute Not yet recruiting
Continue reading on clinicaltrials.govYou might also wanna read
EU digital sovereignty package and promising cancer therapy studies
The article covers two main topics: (1) Promising new cancer therapy studies, with one described as potentially revolutionary, offering hope
zeit.de·1mo agoCRIS Contra el Cáncer financia una nueva estrategia de terapias dirigidas frente al cáncer de ovario
Infobae·3d ago
Modellprojekt mit vorbereitendem Workshop zur Implementierung und Evaluierung einer Interventionsstrategie zur Verbesserung der Arzneimitteltherapiesicherheit (AMTS) bei Patientinnen und Patienten mit oraler Tumortherapie
bundesgesundheitsministerium.de·4h ago
New cancer drug trial offers hope for patients with rare aggressive tumour
Reading Chronicle·2d ago
Why a cancer researcher with a high genetic risk wants AI development to slow down
A personal essay from someone with a high genetic cancer risk who has spent years working toward AI-driven cancer detection. Despite persona
theatlantic.com·16d agoWhy a cancer researcher with a high genetic risk wants AI development to slow down
A personal essay from someone with a high genetic cancer risk who has spent years working toward AI-driven cancer detection. Despite persona
theatlantic.com·16d ago
New drug for cancer patients with ‘limited’ treatment options enters clinical trial
The Independent·3d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.